Let’s read an article a month – April 2021

The cropped screenshot of the first page of the article. It also includes the URL or link to the article.

Every month I try to read an open-access article. After reading the article, I share the title and associated link with my followers. This is to encourage clinicians to read articles, stay up to date, and continue to grow.

This month I found a great piece to share with you.  This one is about chronic bronchitis. The objective of this paper is to “assess the prevalence of chronic bronchitis in young adults in a Swedish population-based birth cohort and to identify early-life risk factors, including environmental exposures, for disease development” (p2). 


Assessment of chronic bronchitis and risk factors in young adults: results from BAMSE

By: Gang Wang, Jenny Hallberg, Petra Um Bergström, Christer Janson, Göran Pershagen, Olena Gruzieva, Marianne van Hage, Antonios Georgelis, Anna Bergström, Inger Kull, Anders Lindén, and Erik Melén. 

European Respiratory Journal (ERJ) 2021 57: 2002120 ; DOI: 10.1183/13993003.02120-2020

Link to the ERJ page: https://erj.ersjournals.com/content/57/3/2002120?etoc

Link to the pdf page: https://erj.ersjournals.com/content/erj/57/3/2002120.full.pdf


3 Reasons why I found this article interesting

  • Authors comment on the impact of cigarette and e-cigarettes and chronic bronchitis in young adults (direct and indirect). Also, authors included factors such as breastfeeding as a protective factor which is something I would not have immediately thought of.
  • It includes a 24-year follow up assessment. They have excluded asthmatic patients to make their observation more accurate.  Various assessment tools were included, including self-assessments, pre and post spirometry, and FeNO2. 
  • This study reminded me that this condition “may exist with our without airway obstruction” p7.

What’s your experience with chronic bronchitis in young adults? Have you noticed a pattern?

Happy learning and reading!

Farzad Refahi
April 16, 2021

https://respiratory.blog/lets-read-an-article-a-month-April-2021/

Let’s read an article a month – February 2021

The cropped screenshot of the first page of the article. It also includes the URL or link to the article.

Every month I try to read an open-access article. After reading the article, I share the tittle and associated link with my followers. This is to encourage clinicians to read articles, stay up to date, and continue to grow.

Link to the article: https://erj.ersjournals.com/content/56/6/2000556?etoc

Link to the blog post: https://respiratory.blog/lets-read-an-article-a-month-february-2021/

This month I found a great piece to share with you.  This one is a prospective, open-label, single-arm study. The objective of this paper is to “evaluate the feasibility, efficacy and safety of metered cryospray therapy to treat patients with chronic bronchitis in COPD”  p3.


A prospective safety and feasibility study of metered cryospray for patients with chronic bronchitis in COPD

By Justin L. Garner, Tawimas Shaipanich, Jorine E. Hartman, Christopher M. Orton, Cielito Caneja, Karin Klooster, John Thornton, Don D. Sin, Dirk-Jan Slebos and Pallav L. Shah.

Eur Respir J 2020 56:2000556; published ahead of print 2020,

doi:10.1183/13993003.00556-2020
Link to the article: https://erj.ersjournals.com/content/56/6/2000556?etoc


Reasons I found this article interesting 

  • I didn’t know about metered cryospray therapy (MCS) and this article introduced me to its application in chronic bronchitis. Its intent is to “cryoablate abnormal epithelium and excessive mucous-producing goblet cells” p2.
  • The method of application is clearly explained in this article.  On page 3, the authors explain the three treatments and which lobes and airway pathways received the MCS therapy in each of those treatment sessions. 

While I am still unsure about the safety of this therapy until further research and improvements are done, I enjoyed learning about the unique approach.  I say this as the sample was only 34 subjects.  Also, “no definitive histological differences were observed between baseline and day 60 endobronchial biopsies” p10. 

If you were not aware of this therapy, this may be a good article for you to read. If you have applied this therapy in the past, I would love to hear about your thoughts and experiences.  Leave a comment and let me know!

Happy learning!

Farzad Refahi

Feb. 1st, 2021

https://respiratory.blog/lets-read-an-article-a-month-february-2021/